![Brenda McLaughlin](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Brenda McLaughlin
General Counsel bei Alamo Pharmaceuticals LLC
Profil
Brenda McLaughlin is the Head of Government Affairs for Alamo Pharmaceuticals LLC.
She was a Director of the Pennsylvania Department of Health.
Ms. McLaughlin received a BS degree from Pennsylvania State University.
Aktive Positionen von Brenda McLaughlin
Unternehmen | Position | Beginn |
---|---|---|
Alamo Pharmaceuticals LLC
![]() Alamo Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Alamo Pharmaceuticals LLC markets and develops pharmaceutical products. The company's product FazaClo (clozapine) is used to treat patients with severe schizophrenia. It is also testing the drug in conjunction with schizophrenia treatments to reduce the side effects of anti-psychotic drugs. The company was founded by Neal R. Cutler and is headquartered in Beverly Hills, CA. | General Counsel | - |
Ehemalige bekannte Positionen von Brenda McLaughlin
Unternehmen | Position | Ende |
---|---|---|
UNIVEST FINANCIAL CORPORATION | Direktor/Vorstandsmitglied | - |
Ausbildung von Brenda McLaughlin
The Pennsylvania State University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
UNIVEST FINANCIAL CORPORATION | Finance |
Private Unternehmen | 1 |
---|---|
Alamo Pharmaceuticals LLC
![]() Alamo Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Alamo Pharmaceuticals LLC markets and develops pharmaceutical products. The company's product FazaClo (clozapine) is used to treat patients with severe schizophrenia. It is also testing the drug in conjunction with schizophrenia treatments to reduce the side effects of anti-psychotic drugs. The company was founded by Neal R. Cutler and is headquartered in Beverly Hills, CA. | Health Technology |